September 18, 2022
Video

Three-Year Outcomes of the Randomized SCOPE I Trial Comparing the ACURATE Neo Versus the SAPIEN 3 Transcatheter Heart Valve System in Patients With Symptomatic Severe Aortic Stenosis

Video Player is loading.
Current Time 0:00
Duration 4:57
Loaded: 0%
Stream Type LIVE
Remaining Time 4:57
 
1x
  • Chapters
  • descriptions off, selected
  • captions off, selected
  • en (Main), selected

04:57

Yazan Daaboul and Jonas Lanz discuss Three-Year Outcomes of the Randomized SCOPE I Trial at TCT 2022